Search

Shabnam Samankan, MD
Shabnam Samankan MD, is an assistant professor of gynecologic, breast and ENT pathology in the Department of Pathology at George Washington University (GW) and the Division Chief of Head & Neck and Endocrine Pathology. Prior to joining GW, Dr. Samankan completed a subspecialty fellowship…
Rebecca Yee, PhD, D(ABMM)
Rebecca Yee, Ph.D, D(ABMM) is the Chief of Microbiology and Assistant Professor in the Department of Pathology at George Washington University.
A Randomized, Placebo-controlled, Double-blind Study of Adjuvant Cemiplimab versus Placebo after Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma
Primary objective: The primary objective of the study is to compare disease-free survival (DFS) of patients with high-risk cutaneous squamous cell carcinoma (CSCC) treated with adjuvant cemiplimab, versus those treated with placebo, after surgery and radiation therapy (RT).
A Phase I Study of Ipilimumab and Nivolumab in Advanced HIV-Associated Solid Tumors, with Expansion Cohorts in HIV-Associated Solid Tumors and a Cohort of HIV-Associated Classical Hodgkin Lymphoma
Primary Outcome Measure: Maximum tolerated dose of nivolumab [Time Frame: 56 days] Will be defined as the starting dose level at which 1/6 subjects experience dose limiting toxicity (DLT) with the next higher dose having at least >= 2 participants encountering DLT. Toxicity data will be…
Lab Services
KPL-716-C201: A Phase 2A/B, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of KPL-716 in Reducing Pruritus in Subjects with Prurigo Nodularis
Have at least 20 nodules of approximately 0.5 to 2 cm. The nodules must be pruritic and present on at least 2 different anatomical locations (not be localized), involve the extremities, with extensor extremity involvement greater than the flexor extremity involvement. Nodules on the head (face and…